|
Tuberculosis
that is “resistant to all drugs”
 Recently,
a published study described four patients from India with resistance to all
tested drugs for tuberculosis (TB).
WHO defines the cases of drug-resistant TB in India as extensively-drug
resistant TB or XDR-TB, as reliable tests to confirm total resistance to
some TB drugs are not available. These serious cases raise the alarm for
better managed TB care and treatment, particularly in the private sector.
Severe resistance to available medicines occurs when below-standard care
and treatment by health providers is allowed to go unchecked. WHO is working closely with the Indian
Ministry of Health and Family Welfare to provide accurate diagnostic and treatment
advice to those affected and to strengthen the surveillance system.
More Info…
|
|
Fifteenth
Meeting of National TB Programme Managers and
Partners, 6-9 December 2011
 The 15th Meeting of the National TB Programme Managers and Partners of the WHO South-East
Asia Region was held in Bangkok, Thailand on 6- 9 December 2011. The general objectives of the meeting
were to further strengthen and improve implementation of the Stop TB
Strategy towards achieving TB targets as per the Millennium Development
Goals (MDGs), in all Member countries.
Participants from the national TB programmes in
Member countries of the Region, representatives from technical agencies,
and WHO TB staff from the HQ, SEARO and Country offices, attended this
4-day meeting.
More Info…
|
|
Regional
Workshop on Public and Private Mix/ Practical Approach to Lung Health in TB
Control, Kathmandu, 19-23 September 2011
 Countries in the South East Asia Region
have continued to make steady progress with TB control. The number of
notified TB cases has been steadily increasing with more than 2 million TB
patients initiated on treatment in the Region during 2009. Based on data
from National TB programmes in Member countries in
2009, the overall treatment success rate achieved in the Region as a whole
was 88%, close to the current target of 90%.
More Info…
|
|
World TB Day 2011: Strengthening and
innovating strategy to eliminate TB
 Considerable progress has been made in
controlling TB in the Region. Over two million people with TB are being
successfully treated every year in the countries of the Region. As a
result, the proportion of the region’s population becoming affected with TB
has been declining each year since 1990 and death rates are falling. The slogan for World TB Day 2011
“Strengthening and innovating strategy to eliminate TB” reflects this
theme. But the Region is still home
to one out of three people with TB in the world. New and better tools to
fight tuberculosis are now available due to important advances in TB
research, particularly in more recent years. At the same time, more
resources are being made available for TB control in countries. We can and
must meet the MDGs if we put in place innovative
approaches and work together in new and different ways.
More…
Press release - WHO: greater
innovation key to fight tuberculosis
Quiz on TB
Top Score
World TB Day 2011: Street Play
[Video: WMV 07:51 min]
|
|
Better diagnostics and new drugs
essential for fighting tuberculosis
 WHO and the STOP TB partnerships are
advocating a new approach to eliminating tuberculosis through improved,
quicker diagnosis, more effective drugs and vaccines and stronger health
systems. This approach has been set out in ”The
Global Plan to Stop TB 2011-2015: Transforming the Fight”, launched today
in Berlin, Germany. The goal is to reach
the UN Millennium Development Goal (MDG) of halting and reversing the TB
epidemic by 2015, and halving the number of deaths due to the disease
compared to 1990 levels. The ultimate aim is to eliminate TB as a public
health problem by 2050.
More…
[PDF 80 KB] The Global Plan
to Stop TB
|
|
 International
Trainings and Workshops on TB
National TB Programme Managers of the Region adopt new target for
TB control
National AIDS and TB
Managers of the SEA Region focus on accelerating interventions to address
HIV associated TB.
|
|
The TB Unit of the WHO Regional Office for South-East
Asia assists countries in the Region in achieving set targets for TB control through policy guidance, advocacy, planning, information exchange, technical support, assistance for human resource development, resource mobilization, monitoring and evaluation and operational
research. Under the Regional Strategic Plan 2006–2015, intensified
action to add impetus to current efforts and promote additional
interventions for TB control is envisaged.
|
|
Highlights
|
|
Continued progress in TB
Control in the SEA Region  Countries in the South-East Asia
Region have continued to make steady progress with TB control. The number
of notified TB cases has been steadily increasing, with more than 2 million
TB patients initiated on treatment in the Region during 2009. Based on 2009
data from national TB programmes in Member
States, nine countries in the Region have now achieved or surpassed the
former 85% treatment success target; the overall treatment success rate
achieved in the Region as a whole was therefore 88%, close to the current
global target of 90%. Major achievements during the year were the
establishment and scaling up of interventions for TB/HIV,
multidrug-resistant TB and further expansion of private and public
partnerships for the provision of TB care in Member States. As a result of
ongoing efforts, TB prevalence and mortality rates have declined by almost
a third compared to the baseline in 1990, while a slower decline in
incidence continues to be maintained.
More…
|
|
NEWS UPDATES
|
|
Steady progress made towards treating TB in Timor-Leste
|
|
Dili: A greater number of new positive
Tuberculosis (TB) cases are being detected now in Timor-Leste compared to
nine years ago. Of these new cases, about 85% are being successfully
treated. Timor Leste’s TB burden was first
recorded in 1995 and averaged 707 cases per 100,000 of its population.
Today it stands at 378 cases per 100,000 of its population. “Timor-Leste is
on track to meeting the MDG goal of halving the number of TB cases in the
country by 2015. The firm and dedicated support from both our national and
international partners have been significant in the control of TB in
Timor-Leste” said Dr Martins at the launch of the country's Stop TB Strategy
for 2011-2015. More…
[PDF 136 KB]
|
|
Stop TB Partnership warns of a temporary shortage of
quality-assured Streptomycin
|
|
Geneva - 10 November 2010 - The Stop TB
Partnership anticipates a temporary shortage of quality-assured
Streptomycin. This shortage, which is also affecting other suppliers, is
related to quality issues of the Active Pharmaceutical Ingredient (API)
source used by one of the main Streptomycin suppliers of the Partnership's
Global Drug Facility (GDF). Additionally, as major donors and technical
agencies have adopted more stringent quality assurance policies, GDF is not
in the short-term able to secure sufficient quantities of Streptomycin that
meet the new stringent criteria. More…
|
|
TB Alliance
Launches First Clinical Trial of a Novel TB Drug Regimen
|
|
BERLIN, Germany —
8 November 2010 - In advance of the 41st Union World Conference, the
Global Alliance for TB Drug Development (TB Alliance) today announced the
launch of the first clinical trial to test a novel tuberculosis regimen in
a new development paradigm designed to speed new treatments to patients.
This novel three-drug combination shows promise to treat both
drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the
course of the TB pandemic by shortening and simplifying treatment
worldwide. More…
|
| News home
>
|
|
|
))
